HU9403821D0 - Anti-acne composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof - Google Patents

Anti-acne composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof

Info

Publication number
HU9403821D0
HU9403821D0 HU9403821A HU9403821A HU9403821D0 HU 9403821 D0 HU9403821 D0 HU 9403821D0 HU 9403821 A HU9403821 A HU 9403821A HU 9403821 A HU9403821 A HU 9403821A HU 9403821 D0 HU9403821 D0 HU 9403821D0
Authority
HU
Hungary
Prior art keywords
layers
deep
simultaneous treatment
skin
superficial
Prior art date
Application number
HU9403821A
Other languages
English (en)
Other versions
HUT71722A (en
Inventor
Alain Ribier
Jean-Thierry Simonnet
Chantal Fanchon
Evelyne Segot
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of HU9403821D0 publication Critical patent/HU9403821D0/hu
Publication of HUT71722A publication Critical patent/HUT71722A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9403821A 1993-12-30 1994-12-29 Anti-acne composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof HUT71722A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9315865A FR2714602B1 (fr) 1993-12-30 1993-12-30 Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.

Publications (2)

Publication Number Publication Date
HU9403821D0 true HU9403821D0 (en) 1995-03-28
HUT71722A HUT71722A (en) 1996-01-29

Family

ID=9454568

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9403821A HUT71722A (en) 1993-12-30 1994-12-29 Anti-acne composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof

Country Status (12)

Country Link
US (1) US5679374A (hu)
EP (1) EP0661036B1 (hu)
JP (1) JP2714541B2 (hu)
AT (1) ATE141781T1 (hu)
BR (1) BR9405482A (hu)
CA (1) CA2138873C (hu)
DE (1) DE69400428T2 (hu)
ES (1) ES2094034T3 (hu)
FR (1) FR2714602B1 (hu)
HU (1) HUT71722A (hu)
PL (1) PL306586A1 (hu)
RU (1) RU2128506C1 (hu)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use
DE19540749A1 (de) * 1995-11-02 1997-05-07 Beiersdorf Ag Kosmetische Zubereitungen mit einem wirksamen Gehalt an Glycosylglyceriden
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US7094422B2 (en) * 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
FR2750049B1 (fr) * 1996-06-21 1998-07-31 Oreal Nouveau procede de preparation de compositions uv-filtrantes compositions susceptibles d'etre obtenues par ce procede et applications
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
FR2768053B1 (fr) * 1997-09-09 1999-10-15 Oreal Compositions photoprotectrices comprenant un benzylidene camphre et/ou un dibenzoylmethane et/ou une triazine et un tartrate de dialkyle; utilisations en cosmetique
IL122084A (en) * 1997-10-31 1999-09-22 Lurident Ltd Formulation for personal care with mucoadhesive properties
US6042841A (en) * 1998-03-16 2000-03-28 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Cosmetic method of treating skin
US6022896A (en) * 1998-09-10 2000-02-08 Chesebrough-Pond's Usa Co. Petroselinic acid as an anti-irritant in compositions containing alpha-hydroxy acids
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US7396526B1 (en) 1998-11-12 2008-07-08 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US6521237B2 (en) 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US6444647B1 (en) 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US6861060B1 (en) 2000-04-21 2005-03-01 Elena Luriya Personal care formulations
CA2407857C (en) * 2000-05-05 2009-11-17 Curtis A. Cole Skin care composition comprising a retinoid, an acid and 2-dimethyl amino ethanol
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
KR20020027198A (ko) * 2000-10-02 2002-04-13 차알스 제이. 메츠 염증과 홍반의 완화방법
US20040213754A1 (en) * 2000-10-02 2004-10-28 Cole Curtis A. Method for cleansing sensitive skin using an alkanolamine
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
JP2004532853A (ja) 2001-05-09 2004-10-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 酒さを治療する目的での組成物の使用
US20050238730A1 (en) * 2001-11-21 2005-10-27 Agnes Le Fur Compositions comprising an ethanolamine derivative and organic metal salts
US20110142922A1 (en) * 2002-04-30 2011-06-16 Ferndale Ip, Inc. Stabilized composition and method for dermatological treatment
ATE388689T1 (de) * 2002-04-30 2008-03-15 Cognis Ip Man Gmbh Verwendung von wirkstoffmischungen mit azelainsäure und glycyrrhetinsäure als anti- aknemittel
DE50211163D1 (de) * 2002-04-30 2007-12-20 Cognis Ip Man Gmbh Mikrokapseln mit Anti-Aknewirkstoffen
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
DE10232774B4 (de) * 2002-07-18 2004-07-15 Cognis Deutschland Gmbh & Co. Kg Kosmetische Zubereitungen mit antibakteriellen Eigenschaften
FR2843125B1 (fr) * 2002-08-02 2012-11-16 Coletica Principes actifs stimulant les beta-defensives humaines de type 2 et/ou de type 3, et compositions cosmetiques ou pharmaceutiques comprenant de tels principes actifs
EP1449533A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-iodine liposomes for the treatment of acne
US20040175347A1 (en) * 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
US20080076720A1 (en) * 2003-03-04 2008-03-27 Sancai Xie Personal care compositions having kinetin or zeatin
US7285570B2 (en) * 2003-04-17 2007-10-23 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue
CA2529953A1 (en) * 2003-06-23 2004-12-29 Transpharma Medical Ltd. Transdermal delivery system for cosmetic agents
US20050043283A1 (en) * 2003-08-22 2005-02-24 L'oreal S.A. Compositions containing topical active agents and pentylene glycol
US20060018852A1 (en) * 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US7416756B2 (en) * 2003-09-10 2008-08-26 Eastman Chemical Company Process for the recovery of a phytolipid composition
US7285544B2 (en) * 2003-11-18 2007-10-23 Bernstein Eric F Use of nitroxides in treating skin disease
US8053000B2 (en) * 2005-06-07 2011-11-08 Dr. Reddy's Laboratories Limited Compositions for drug delivery
EP1948145A2 (en) * 2005-10-24 2008-07-30 Ciba Holding Inc. Protection of oxidizable agents
US20070128137A1 (en) * 2005-12-02 2007-06-07 Naohisa Yoshimi Water in oil emulsion compositions containing siloxane elastomers
DE102006004804A1 (de) * 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen
US20070203040A1 (en) * 2006-02-24 2007-08-30 Harry Reicherz Bar soap
US7252816B1 (en) * 2006-03-29 2007-08-07 Dow Pharmaceutical Sciences Topical acne vulgairs medication with a sunscreen
DE102006015271A1 (de) * 2006-04-01 2007-10-11 Lohmann & Rauscher Gmbh & Co. Kg Biguanidhaltige Liposomen
US20070264210A1 (en) * 2006-05-15 2007-11-15 The Procter & Gamble Company Method of enhancing penetration of water-soluble actives
US20070274932A1 (en) * 2006-05-15 2007-11-29 The Procter & Gamble Company Water in oil emulsion compositions containing sunscreen actives and siloxane elastomers
US8604901B2 (en) * 2006-06-27 2013-12-10 Eyelock, Inc. Ensuring the provenance of passengers at a transportation facility
KR100752990B1 (ko) * 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
US20090137534A1 (en) * 2007-11-26 2009-05-28 Chaudhuri Ratan K Skin treatment compositions and methods
US20090011035A1 (en) * 2007-07-03 2009-01-08 Joseph Michael Zukowski Personal care composition
US20090041686A1 (en) * 2007-08-06 2009-02-12 Osborne David W Topical acne vulgaris composition with a sunscreen
PL2187736T3 (pl) 2007-08-16 2016-01-29 Univ Chicago Odporność na patogeny roślin
FR2947172B1 (fr) * 2009-06-29 2011-09-09 Natura Cosmeticos Sa Composition cosmetique, kit de traitement de la peau, procede pour traiter les peaux grasses, mixtes ou acneiques
KR101443927B1 (ko) 2009-08-20 2014-09-25 (주)아모레퍼시픽 헥사미딘류 및 레티노이드류를 함유하는 피부 개선 조성물
US20110070174A1 (en) * 2009-09-21 2011-03-24 PruGen IP Holdings, Inc. Benzoyl Peroxide and Sunscreen Agent Combination
RU2485955C2 (ru) * 2010-11-17 2013-06-27 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая флуконазол, и/или кетоконазол, и/или тербинафин и липосомы для местного применения
CN102366407B (zh) * 2011-09-14 2013-03-20 海南灵康制药有限公司 盐酸克林霉素棕榈酸酯脂质体固体制剂
WO2019089942A1 (en) * 2017-11-02 2019-05-09 Rick Coulon Formulations for use in the transdermal delivery of proteasome inhibitors
GB201906362D0 (en) * 2019-05-06 2019-06-19 Givaudan Sa Cosmetic ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) * 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
EP0571063A1 (de) * 1989-12-14 1993-11-24 Schering Aktiengesellschaft Pharmazeutische Präparate

Also Published As

Publication number Publication date
RU2128506C1 (ru) 1999-04-10
DE69400428D1 (de) 1996-10-02
DE69400428T2 (de) 1997-01-16
CA2138873A1 (fr) 1995-07-01
HUT71722A (en) 1996-01-29
JP2714541B2 (ja) 1998-02-16
FR2714602B1 (fr) 1996-02-09
US5679374A (en) 1997-10-21
EP0661036B1 (fr) 1996-08-28
PL306586A1 (en) 1995-07-10
EP0661036A1 (fr) 1995-07-05
CA2138873C (fr) 1999-12-14
FR2714602A1 (fr) 1995-07-07
ATE141781T1 (de) 1996-09-15
RU94045285A (ru) 1996-11-10
ES2094034T3 (es) 1997-01-01
JPH07309781A (ja) 1995-11-28
BR9405482A (pt) 1995-09-19

Similar Documents

Publication Publication Date Title
HU9403821D0 (en) Anti-acne composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof
HU9403828D0 (en) Depigmenting composition for the simultaneous treatment of the surface layers and deep layers of the skini and use thereof
HU9403817D0 (en) Composition for combating ageing, acting simultaneously on the surface layers and deep layers of the skin, and use thereof
HU9403819D0 (en) Slimming composition for topical treatment, containing two types of liposomes, and use thereof
HU9403822D0 (en) Cosmetic composition for the simultaneous treatment of the surface and deep layers of the skin, its use
CA2262870A1 (en) Liposome-based topical vitamin d formulation
GR1002807B (el) Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
AU7999787A (en) Active compounds for use in the treatment of tumors
ATE173396T1 (de) Spruehformulierung mit kuehleffekt
AU664101B2 (en) Novel phospholipid derivatives
DK0697885T3 (da) Insulinlignende vækstfaktor II som antitumormiddel
MX9704679A (es) Composicion antibacteriana liposomal de baja rigidez.
CA2148942A1 (en) M-edta pharmaceutical preparations and uses thereof

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee